These findings collectively suggest that CKS1B inhibition suppresses tumor growth and enhances the efficacy of gemcitabine by promoting apoptosis, and CKS1B may facilitate chemotherapy resistance through its regulation of CSCs. The gene discussed is CKS1B; the disease is neoplasm.